1. Home
  2. FBIZ vs SPRY Comparison

FBIZ vs SPRY Comparison

Compare FBIZ & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Business Financial Services Inc.

FBIZ

First Business Financial Services Inc.

HOLD

Current Price

$72.76

Market Cap

529.7M

Sector

Finance

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$4.86

Market Cap

558.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIZ
SPRY
Founded
1909
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
529.7M
558.9M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
FBIZ
SPRY
Price
$72.76
$4.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$66.00
$40.00
AVG Volume (30 Days)
40.2K
1.4M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
2.41%
N/A
EPS Growth
14.23
N/A
EPS
3.28
N/A
Revenue
N/A
$84,278,000.00
Revenue This Year
$15.69
$87.40
Revenue Next Year
$8.47
$81.64
P/E Ratio
$21.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$46.07
$4.91
52 Week High
$73.48
$13.15

Technical Indicators

Market Signals
Indicator
FBIZ
SPRY
Relative Strength Index (RSI) 58.87 34.83
Support Level $69.91 $5.04
Resistance Level $73.48 $8.61
Average True Range (ATR) 1.43 0.26
MACD -0.01 -0.03
Stochastic Oscillator 75.63 3.64

Price Performance

Historical Comparison
FBIZ
SPRY

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products, including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically, all the business activity functioned through the region of the United States.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: